Operating Advisor

Dawn has more than 25 years of experience in outsourced pharma services. Most recently, she was the Chief Growth Officer at WCG, where she oversaw business development, marketing, and sales operations. Dawn's pharma services leadership experience also includes roles as COO at Elligo Health Research, Chief Development Officer at Clinipace Worldwide, President of Development Innovations at Sarah Cannon Research Institute, SVP and GM for Hematology and Oncology at inVentiv Health Clinical, VP and General Partner for Operations at PRA International, and Director of Clinical Operations at PPD. Dawn was previously a Board Member at Deep 6 AI.